1. Ahmann D, O'Fallon J, O'Connel MT, et al: Evaluation of fixed alternating treatment in patients with advanced breast cancer. Cancer Clin Trials 1978;1:219–226.
2. Aisner J, Weinberg V, Perloff M, et al: Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF MER) for metastatic carcinoma of the breast. A CALGB study. J Clin Oncol 1987;5:1523–1533.
3. Aisner J, Korzun, A, Perloff M, et al: A Randomized Comparison of CAF, VATH and VATH Alternating with CMFVP for Advanced Breast Cancer. Proc ASCO 1988;7:27.
4. Allegra JC, Woodcock T, Woolf S, et al: A randomized trial comparing mitoxantrone with doxorubicin in patients with stage IV breast cancer. Invest N Drugs 1985;3:153–161.
5. Antman KS, Griffin JD, Elias A, et al: Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med 1988;319:593–598.